Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jan Budczies is a leading researcher in computational pathology and molecular oncology, with a focus on integrating microfluidic technologies with tumor biology to advance precision medicine. His work centers on developing innovative tools for tissue analytics and molecular subtyping, particularly in breast cancer. A key contribution is the design of a microfluidic sampling system for tissue biopsies, enabling precise extraction of lipid samples for analysis—a proof-of-concept that holds promise for minimally invasive diagnostics. Additionally, Dr. Budczies has made significant strides in RNA-based molecular tumor typing, establishing standardized systems and cutoffs for assessing ESR1 and HER2 expression in formalin-fixed, paraffin-embedded (FFPE) tissue. This work, validated in the GeparQuinto-PREDICT substudy, provides a framework for predicting responses to neoadjuvant chemotherapy by evaluating immunological infiltrates and molecular subtypes. While his most-cited papers have garnered modest citation counts (6 and 2, respectively), their impact lies in laying foundational methodologies for tissue sampling and tumor classification. Dr. Budczies’ interdisciplinary approach—bridging microfluidics, pathology, and genomics—positions him as a pioneer in translational cancer research, with potential to reshape diagnostic workflows and therapeutic strategies.